← All trials
NCT06758557
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2024
- Primary completion
- Oct 31, 2025
- Completion date
- Feb 28, 2026
- First posted
- Jan 3, 2025
- Last posted
- Jan 23, 2025
- Enrollment
- 282
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Huabo Biopharm Co., Ltd.Lead sponsor
- Sun Yat-Sen UniversityOfficial
- Huazhong University of Science and TechnologyOfficial
- Zhejiang Huahai Pharmaceutical Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.